375 related articles for article (PubMed ID: 18854458)
1. Full disclosure.
Maxwell D
Can Fam Physician; 2008 Oct; 54(10):1377-8; discussion 1378. PubMed ID: 18854458
[No Abstract] [Full Text] [Related]
2. [Publication ethics: regulation of financial conflicts of interests in medical journals].
Kakuk P
Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
[No Abstract] [Full Text] [Related]
3. [Knowledge on feet of clay].
Dahlqvist R
Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
[No Abstract] [Full Text] [Related]
4. Disclosing conflicts of interest in biomedical research.
Reilly PR
J Periodontol; 2007 Aug; 78(8):1472-5. PubMed ID: 17668964
[No Abstract] [Full Text] [Related]
5. GSK is accused of trying to suppress editorial on rosiglitazone.
Tanne JH
BMJ; 2010 May; 340():c2654. PubMed ID: 20484354
[No Abstract] [Full Text] [Related]
6. Research dishonesty and conflict of interest.
Frizelle F
N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
[No Abstract] [Full Text] [Related]
7. A new policy on financial disclosure.
Nat Neurosci; 2001 Oct; 4(10):961. PubMed ID: 11574824
[No Abstract] [Full Text] [Related]
8. The sins of ghostwriting.
Somberg JC
Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328
[No Abstract] [Full Text] [Related]
9. Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
Avanzini G; Engel J
Epilepsia; 2007 Oct; 48(10):1821-4. PubMed ID: 17683507
[No Abstract] [Full Text] [Related]
10. [Conflicts of interest--an evidence-based approach].
Slørdal L; Eggen AE; Rygnestad T
Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864
[No Abstract] [Full Text] [Related]
11. Caveat lector.
Gershen BJ
Md Med; 2007; 8(1):15-6. PubMed ID: 17472148
[No Abstract] [Full Text] [Related]
12. Conflict of interest: will it ever end?
Carney SL
Intern Med J; 2012 Nov; 42(11):1255-6. PubMed ID: 23157520
[TBL] [Abstract][Full Text] [Related]
13. In reply.
Schott G; Pachl H; Ludwig WD; Dünnweber C; Mühlbauer B; Niebling W
Dtsch Arztebl Int; 2014 Jan; 111(3):37-8. PubMed ID: 24606786
[No Abstract] [Full Text] [Related]
14. Response to "the corporate coauthor".
Wager E; Jacobs A
J Gen Intern Med; 2005 Jul; 20(7):672. PubMed ID: 16050869
[No Abstract] [Full Text] [Related]
15. [Ghostwriting].
Haug C
Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881
[No Abstract] [Full Text] [Related]
16. Transparency is key.
Follmann M
Dtsch Arztebl Int; 2014 Jan; 111(3):37. PubMed ID: 24606785
[No Abstract] [Full Text] [Related]
17. Manipulated evidence?
Strömer K; Reusch M
Dtsch Arztebl Int; 2014 Jan; 111(3):36-7. PubMed ID: 24606784
[No Abstract] [Full Text] [Related]
18. No robust argument.
Prinz JC; Streit V
Dtsch Arztebl Int; 2014 Jan; 111(3):35-6. PubMed ID: 24606782
[No Abstract] [Full Text] [Related]
19. Information advantage or conflicts of interest?
Kaufmann R
Dtsch Arztebl Int; 2014 Jan; 111(3):36. PubMed ID: 24606783
[No Abstract] [Full Text] [Related]
20. Confirming the hypothesis at any cost?
Nast A; Rzany B
Dtsch Arztebl Int; 2014 Jan; 111(3):35. PubMed ID: 24606781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
